Product Information
CLOTRIMAZOLE 1% TOPICAL CREAM is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1989 per GM under NDC 68462018117. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 3, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462018117
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOTRIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA090219FDA Approved
8/3/2010
TE Code
AB
On Market Since
8/4/2010
Pharmacological Classes
Price Statistics
The NADAC for CLOTRIMAZOLE 1% TOPICAL CREAM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 74.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1989 per GM |
|---|---|
| All-time high | $0.8107 (Mar 12, 2014) |
| All-time low | $0.1701 (Nov 20, 2024) |
| 52-week high | $0.2160 |
| 52-week low | $0.1973 |
| Median price | $0.2680 |
| Average price | $0.3821 |
| Largest weekly change | +35.5% (Jul 22, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 57% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clotrimazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOTRIMAZOLE 1% TOPICAL CREAM?
The current National Average Drug Acquisition Cost (NADAC) for CLOTRIMAZOLE 1% TOPICAL CREAM, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1989 per GM (NDC 68462018117), effective Sep 30, 2026.
How has the price of CLOTRIMAZOLE 1% TOPICAL CREAM changed over time?
Over the history we have for it, the NADAC for CLOTRIMAZOLE 1% TOPICAL CREAM has declined 74.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLOTRIMAZOLE 1% TOPICAL CREAM?
Since Nov 28, 2013, the NADAC for CLOTRIMAZOLE 1% TOPICAL CREAM has ranged from a low of $0.1701 (Nov 20, 2024) to a high of $0.8107 (Mar 12, 2014), with a median of $0.2680 per GM.
Are there cheaper alternatives to CLOTRIMAZOLE 1% TOPICAL CREAM?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FT CLOTRIMAZOLE 1% VAG CREAM, is $0.0865 per GM — about 57% below CLOTRIMAZOLE 1% TOPICAL CREAM.
Who manufactures CLOTRIMAZOLE 1% TOPICAL CREAM?
CLOTRIMAZOLE 1% TOPICAL CREAM (NDC 68462018117) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.